FUTURE FARM SUBSIDIARY AWARDED LICENSE FOR RESEARCH
License issued to CEPG under Health Canadas Cannabis Act and Cannabis Regulations
April 9, 2020 Vancouver, British Columbia – Future Farm Technologies Inc. (the Company, Future Farm or FFT) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that its subsidiary, CEPG Consulting and Design Inc. (CEPG), located in St. Johns, Newfoundland, has been issued a cannabis research license in accordance with Health Canadas Cannabis Act and Cannabis Regulations.
The license authorizes CEPG to possess and produce cannabis for the purpose of research activities at its locations in Jackson’s Arm and St. John’s and at Memorial University of Newfoundland. Health Canadas Research Protocol requires the research to be for: Creation, classification and characterization of elite Cannabis clones with a profile of Cannabinoids and terpenes specifically selected for pharmaceutical and industrial applications.
We are thrilled to receive this cannabis research license from Health Canada, says Future Farm CEO William Gildea. This license allows us to begin work creating elite new strains of cannabis and is the first step towards reaching our ultimate goal of mass-producing elite cannabis plant clones for sale throughout Canada. We could not have achieved this milestone without the leadership and hard work of CEPGs President and CEO, Mr. H.C. Snellen, CFO and Director Mr. H.B. Chislett and regulatory specialist Mr. Gary Harnum.
For further information, contact Investor Relations at investor@FutureFarmTech.com.
On behalf of the Board,
Future Farm Technologies Inc.
William Gildea, CEO & Chairman
About Future Farm Technologies Inc.
Future Farm Technologies is a Canadian public company that is poised to be a leading supplier of pharma-grade health and wellness products, including those made from hemp, to meet the burgeoning demand in the U.S. and global markets.
Future Farms seasoned management team brings a deep understanding of operations and agriculture with the financial and regulatory expertise needed to become an industry leader in the rapidly growing market for health and wellness products made from hemp and other plants.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. There is no guarantee that the Company will be successful in its efforts to further develop its existing hemp operations, or that the Company will be able to raise sufficient capital to execute on its intended business plan and objectives. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.